Business Context and Reporting Period
This Form 8-K, filed on October 3, 2022, reports events occurring as of September 30, 2022, concerning Chardan NexTech Acquisition 2 Corp. (the "Company") and its proposed business combination with Dragonfly Energy Corp. Upon closing, the Company will be renamed "Dragonfly Energy Holdings Corp." The filing details a significant modification to the Private Investment in Public Equity (PIPE) transaction originally agreed upon with the Company's Sponsor.
Key Financial Metrics and Transaction Details
- Original PIPE Commitment: The Sponsor initially agreed to purchase 500,000 shares of Common Stock at $10.00 per share for gross proceeds of $5 million.
- Open Market Purchases: As of September 30, 2022, the Assignee (formerly the Sponsor) acquired 485,000 shares in the open market at prices ranging from $10.33 to $10.38 per share.
- Revised PIPE Obligation: Due to an offset provision in the Subscription Agreement, the obligation to purchase new shares was reduced from 500,000 to 15,000 shares. Consequently, the aggregate purchase price obligation was reduced from $5 million to zero.
- Voting Rights: The Assignee waived voting rights for the 485,000 shares purchased in the open market regarding the Special Meeting of Stockholders on October 6, 2022.
- Financial Statements: This filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company or Dragonfly Energy.
Material Changes Versus Prior Period
The primary material change reported is the effective cancellation of the $5 million PIPE investment obligation. The Assignee's open market purchases of 485,000 shares triggered a contractual offset that eliminated the requirement to purchase the remaining 15,000 shares under the Subscription Agreement. Additionally, the Sponsor assigned its rights and obligations under the Subscription Agreement to Chardan Capital Markets LLC (the "Assignee") on September 28, 2022.
Guidance, Outlook, Risks, and Contingencies
Outlook and Management Commentary: Management does not believe the waiver of voting rights for the open market shares will materially impact the likelihood of the Business Combination's approval. The filing contains extensive forward-looking statements regarding the future operations of the combined entity, including revenue projections and growth strategies, which are subject to significant uncertainty.
Risks and Contingencies: The filing lists numerous risks that could cause actual results to differ from projections, including:
- Failure to obtain stockholder approval or meet closing conditions.
- Inability to maintain Nasdaq listing standards post-combination.
- Operational risks related to Dragonfly's solid-state cell technology, including scaling to mass production.
- Supply chain dependencies, specifically reliance on two suppliers for LFP cells and a single supplier for battery management systems.
- Need for additional capital to fund operations and achieve profitability.
- Regulatory and legal challenges, including potential litigation.
Investor Verification Checklist
- Verify the final vote count and approval status of the Business Combination at the Special Meeting of Stockholders held on October 6, 2022.
- Confirm the exact number of shares (15,000) the Assignee is still obligated to purchase and the timing of this transaction.
- Review the Proxy Statement/Prospectus (filed September 16, 2022) for detailed financial projections and risk factors not fully elaborated in this 8-K.
- Monitor Dragonfly's progress on solid-state cell commercialization and mass production capabilities.
- Assess the combined company's liquidity position and ability to raise additional capital post-merger.